NESS ZIONA, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, announced today that it has received complementary funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback